Skip to main content
. Author manuscript; available in PMC: 2012 Jul 22.
Published in final edited form as: Arch Neurol. 2011 Jun;68(6):753–760. doi: 10.1001/archneurol.2011.107

Table 1.

Subject demographics and clinical characteristics of all PSP subjects

Controls (n=20) PSP (n=20)
Gender (% female) 11 (55%) 10 (50%)
Education (yrs) 14.9 ± 2.9 14.5 ± 2.5
Age at exam (yrs) 69.4 ± 7.3 68.3 ± 7.2
Age at onset (yrs) NA 64.7 ± 6.9
Time onset to exam (yrs) NA 3.6 ± 1.8
FBI (/72) NA 11.2 ± 11.4
FAB (/18) NA 13.7 ± 2.1
PSPRS (/100) NA 35.5 ± 15.7
PSIS (/5) NA 3.1 ± 0.7
MMSE (/30) NA 27.3 ± 3.7
MDS-UPDRS I (/52) NA 10.0 ± 4.6
MDS-UPDRS II (/52) NA 19.0 ± 10.8
MDS-UPDRS III (/132) NA 38.5 ± 16.2

FBI = Frontal Behavioral Inventory; FAB = Frontal Assessment Battery; PSPRS = PSP Rating Scale; PSIS = PSP Saccadic Impairment Scale; MMSE = Mini-Mental State Examination; MDS-UPDRS = Unified Parkinson’s Disease Rating Scale